M&L Healthcare
Overview
M&L Healthcare is a Singapore-based, family-owned venture capital firm founded in 2019 that invests in the life sciences, HealthTech, and MedTech sectors. It is the healthcare investment arm of the diversified M&L Group, founded by shipping tycoon Michael Kum and his wife Lynda. The firm's strategy is to invest in medical technologies that significantly improve patient outcomes and reduce healthcare costs. Although the firm was formally founded in 2019, its first investment was in 2014.
Portfolio Companies
5
Website
mnlhealthcare.comInvestments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Endovascular Engineering, Inc. | Apr 2026 | Series C | Co-investor |
| CorFlow Therapeutics AG | Sep 2024 | Series B | Co-investor |
| CorWave | Jan 2021 | Series C | Co-investor |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is M&L Healthcare based?
M&L Healthcare is headquartered in Singapore, Central Singapore, Singapore.
When was M&L Healthcare founded?
Founding year information for M&L Healthcare is not publicly available.
How many portfolio companies does M&L Healthcare have?
M&L Healthcare has 5 portfolio companies in Caplight's dataset.
What are some companies in M&L Healthcare's portfolio?
Portfolio companies visible on Caplight include Endovascular Engineering, Inc., CorFlow Therapeutics AG, CorWave.
What was M&L Healthcare's most recent investment shown here?
M&L Healthcare's most recent investment in this portfolio sample was in Endovascular Engineering, Inc. in 2026.
What sectors does M&L Healthcare focus on?
M&L Healthcare focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences.
What company stages does M&L Healthcare focus on?
M&L Healthcare typically invests at the Mid stage.
What is M&L Healthcare's AUM?
M&L Healthcare's assets under management are estimated between $63.0M and $190.0M.